RuXian-I has been shown to reduce the upregulation of TCTP, Mcl-1, and Bcl-xL in breast tissue of the mammary gland, which can facilitate apoptosis and potentially inhibit tumor growth [159]. Here, TPT1 is linked to neoplasm.